All Blogs & News

In this issue: Comprehensive review article on bone marrow surveillance of SDS patients by Drs. Shimamura and Reilly; and a recap of ASH...

Dr. Eszter Hars (SDS Alliance president and CEO) joined the FDA CBER OTAT Patient-Focused Drug Development Listening Meeting.

In this issue: Rare-X report provides update on the true number of rare diseases; new review article on bone marrow failure disorders by...